ArticleFrontiers in immunology2023

NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation.

Qi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.